An AI drug discovery company using physics-informed models and molecular optimisation to design small molecules, peptides, and proximity inducers.
Receptor.AI
Released May 29, 2025
Protein-ligand docking model for high-throughput virtual screening, predicting binding poses with graph neural networks at low computational cost.